Previous 10 | Next 10 |
IQVIA Holdings Inc. (IQV) Q2 2022 Earnings Conference Call July 21, 2022 9:00 am ET Company Participants Ari Bousbib - Chairman, Chief Executive Officer Ron Bruehlman - Executive Vice President, Chief Financial Officer Mike Fedock - Senior Vice President, Financi...
IQVIA press release ( NYSE: IQV ): Q2 Non-GAAP EPS of $2.44 beats by $0.06 . Revenue of $3.54B (+2.9% Y/Y) beats by $50M . R&D Solutions quarterly bookings continue at historic high of over $2.6 billion R&D Solutions contracted backlog of $25.6 bill...
Revenue of $3,541 million grew 3.0 percent year-over-year on a reported basis and 7.1 percent at constant currency GAAP Net Income of $256 million grew 46.3 percent year-over-year Adjusted EBITDA of $800 million grew 10.8 percent year-over-year GAAP Dilut...
Although the healthcare sector has largely resisted this year's downward pressure, it is likely to succumb as pressure increases. Healthcare stocks have a well-deserved reputation for cyclical defense, but they are more likely to underperform in "secular" bear markets. Healthcare ...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its second-quarter 2022 financial results before the market opens on Thursday, July 21, 2022. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings ...
IQVIA ™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced the company has been named a Leader in the IDC MarketScape: Worldwide Life Science Sales and Marketing IT ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech stocks have been brought low over the past 18 months. Both the iShares Biotechnology ETF (NASDAQ: IBB ) and S&P Biotech ETF (NYSEARCA: XBI ), Wall Street’s two most popular funds that track th...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech stocks have suffered significant setbacks during the first half of the year. Investors had little appetite for innovation-driven companies, seeking safe haven in more traditional stocks delivering steady profits...
Citing the recent challenges in the patient enrollment, the pharmacy chain operator Walgreens Boots Alliance (NASDAQ:WBA) announced the launch of its clinical trial business on Thursday to expedite the drug development process. Arguing that COVID-19 has exacerbated the difficulties in patient...
IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and contract services to the life sciences industry, today announced the appointment of Dr. Christina Mack to serve as chief scientific officer for the company’s Real World Solutions (RWS) bus...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 10:00:13 ET Jailendra Singh from Truist Financial issued a price target of $300.00 for IQV on 2024-07-23 09:26:00. The adjusted price target was set to $300.00. At the time of the announcement, IQV was trading at $240.265. The overall price target consensus is...
2024-07-23 10:00:11 ET Elizabeth Anderson from Evercore ISI issued a price target of $270.00 for IQV on 2024-07-23 08:59:00. The adjusted price target was set to $270.00. At the time of the announcement, IQV was trading at $239.5. The overall price target consensus is at...
2024-07-23 07:00:06 ET Luke Sergott from Barclays issued a price target of $275.00 for IQV on 2024-07-23 05:25:00. The adjusted price target was set to $275.00. At the time of the announcement, IQV was trading at $245.23. The overall price target consensus is at $273.93 ...